(Q34225902)

31 July 2017

1 reference

title

Estrogen-responsive RING finger protein controls breast cancer growth (English)

1 reference

31 July 2017

Kuniko Horie

1

1 reference

31 July 2017

Tomohiko Urano

series ordinal

2

1 reference

31 July 2017

Kazuhiro Ikeda

series ordinal

3

1 reference

31 July 2017

Satoshi Inoue

series ordinal

4

1 reference

31 July 2017

publication date

1 June 2003

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

31 July 2017

published in

1 reference

31 July 2017

volume

85

1 reference

31 July 2017

issue

2-5

1 reference

31 July 2017

page(s)

101-104

1 reference

Endocrine-responsive breast cancer and strategies for combating resistance

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Isolation of estrogen receptor-binding sites in human genomic DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Isolation of estrogen-responsive genes with a CpG island library

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Mechanisms underlying ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

PML protein isoforms and the RBCC/TRIM motif

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Molecular cloning of rat efp: expression and regulation in primary osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Efp as a primary estrogen-responsive gene in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900209-7

7 January 2021

10.1016/S0960-0760(03)00209-7

Identifiers

DOI

1 reference

31 July 2017

1 reference